Nerviano Medical Sciences is a provider of R&D services include oncology drug discovery, preclinical research, clinical development.
Nerviano Medical Sciences has raised $220.9M in total funding. The most recent round was Private Equity. The last funding was announced in January 2022.
Nerviano Medical Sciences's investors include PAG.
Nerviano Medical Sciences is headquartered in Nerviano, Italy.
Nerviano Medical Sciences is a provider of R&D services include oncology drug discovery, preclinical research, clinical development.
Nerviano Medical Sciences is at the Private Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Nerviano Medical Sciences — Funding & Investors." VCBacked, January 21, 2022, https://www.vcbacked.co/company/nerviano-medical-sciences. Accessed September 30, 2026.
VCBacked. (2022). Nerviano Medical Sciences — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/nerviano-medical-sciences
{{cite web |title=Nerviano Medical Sciences — Funding & Investors |url=https://www.vcbacked.co/company/nerviano-medical-sciences |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated